Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Department of Gynecology and Obstetrics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia.
Behav Med. 2024 Apr-Jun;50(2):118-129. doi: 10.1080/08964289.2022.2132202. Epub 2022 Oct 21.
Anxiety is one of the most common causes of withdrawal from follow-up among women with abnormal Papanicolaou screening results. The purpose of this study was to investigate predictors of anxiety in women with abnormal Papanicolaou smear in cervical cancer screening program. A population-based, cross-sectional study concerning the factors related to anxiety was carried out during 2017 in a cohort of women ( = 172) with positive Papanicolaou screening test before and after diagnostic procedures (colposcopy/biopsy/endocervical curettage) at one university Clinical Center in Serbia. Women completed a socio-demographic questionnaire and scale concerning anxiety (Hospital Anxiety and Depression Scale, subscale HADS-Anxiety) immediately before and 2-4 weeks after the diagnostic procedures. Multivariate logistic regression was applied in the data analysis. In our study, 35.2% ( = 52) of women had abnormal anxiety scores before the diagnostic procedures and 40.1% ( = 69) after the diagnostic procedures. Predictors of anxiety before diagnostic procedures were family history of noncervical gynecological cancers, higher level of worry and high burden of depressive symptoms. Significant independent predictors of anxiety after diagnostic procedures in women were rural residence, tension and discomfort during medical procedures, and less satisfaction with information/support. Although there was no significant difference in the prevalence of anxiety before and after diagnostic procedures in women with abnormal Papanicolaou screening results, results of this research will enable doctors to successfully make decisions concerning timely psychological support for women with positive screening test for cervical cancer that is necessary to decrease anxiety in our population.
焦虑是导致巴氏涂片检查结果异常的女性退出随访的最常见原因之一。本研究旨在探讨宫颈癌筛查项目中巴氏涂片检查异常女性焦虑的预测因素。2017 年，在塞尔维亚一家大学临床中心，对一组在诊断程序（阴道镜检查/活检/宫颈内膜刮宫术）之前和之后巴氏涂片检查呈阳性的女性（共 172 名）进行了一项基于人群的横断面研究，旨在调查与焦虑相关的因素。女性在诊断程序之前和之后 2-4 周立即完成社会人口统计学问卷和焦虑量表（医院焦虑和抑郁量表，HADS-Anxiety 子量表）。在数据分析中应用了多变量逻辑回归。在我们的研究中，35.2%（52 名）的女性在诊断程序之前有异常的焦虑评分，40.1%（69 名）的女性在诊断程序之后有异常的焦虑评分。诊断程序前焦虑的预测因素包括非宫颈妇科癌症的家族史、更高的担忧程度和更高的抑郁症状负担。诊断程序后女性焦虑的显著独立预测因素是农村居住、医疗过程中的紧张和不适，以及对信息/支持的满意度较低。尽管巴氏涂片检查异常的女性在诊断程序前后焦虑的患病率没有显著差异，但这项研究的结果将使医生能够成功地为宫颈癌阳性筛查的女性做出及时提供心理支持的决策，这对于降低我们人群中的焦虑是必要的。
